- Home
- TATT vs TNGX Comparison
TATT vs TNGX Comparison
Compare TATT & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TATT
- TNGX
- Stock Information
- Founded
- TATT 1985
- TNGX 2014
- Country
- TATT Israel
- TNGX United States
- Employees
- TATT N/A
- TNGX N/A
- Industry
- TATT Aerospace
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- TATT Industrials
- TNGX Health Care
- Exchange
- TATT Nasdaq
- TNGX Nasdaq
- Market Cap
- TATT 282.7M
- TNGX 317.4M
- IPO Year
- TATT 1987
- TNGX N/A
- Fundamental
- Price
- TATT $28.20
- TNGX $1.47
- Analyst Decision
- TATT
- TNGX Strong Buy
- Analyst Count
- TATT 0
- TNGX 7
- Target Price
- TATT N/A
- TNGX $12.33
- AVG Volume (30 Days)
- TATT 51.4K
- TNGX 835.4K
- Earning Date
- TATT 03-26-2025
- TNGX 05-07-2025
- Dividend Yield
- TATT N/A
- TNGX N/A
- EPS Growth
- TATT 96.08
- TNGX N/A
- EPS
- TATT 1.00
- TNGX N/A
- Revenue
- TATT $152,116,000.00
- TNGX $42,069,000.00
- Revenue This Year
- TATT $33.56
- TNGX N/A
- Revenue Next Year
- TATT $14.09
- TNGX N/A
- P/E Ratio
- TATT $27.97
- TNGX N/A
- Revenue Growth
- TATT 33.68
- TNGX 15.17
- 52 Week Low
- TATT $10.61
- TNGX $1.43
- 52 Week High
- TATT $33.37
- TNGX $12.02
- Technical
- Relative Strength Index (RSI)
- TATT 59.46
- TNGX 28.54
- Support Level
- TATT $23.92
- TNGX $1.48
- Resistance Level
- TATT $29.40
- TNGX $1.66
- Average True Range (ATR)
- TATT 1.24
- TNGX 0.16
- MACD
- TATT 0.37
- TNGX -0.00
- Stochastic Oscillator
- TATT 78.42
- TNGX 6.56
About TATT TAT Technologies Ltd.
TAT Technologies Ltd is a provider of solutions and services to the aerospace and defence industries focused mainly on the four segments: Original equipment manufacturing (OEM); MRO services for heat transfer; MRO services for aviation components; Overhaul and coating of jet engine components. The company designs, develops, and manufactures Heat Exchangers, Cooling Systems, Cold Plates, Vapor-Cycle Air Conditioning Systems (for both land and airborne applications), and flow accessories.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.